Fusobacterium Nucleatum in Colorectal Cancer: Relationship Among Immune Modulation, Potential Biomarkers and Therapeutic ImplicationsDalila Incognito, Massimiliano Berretta, Tindara Franchina et al.|International Journal of Molecular Sciences|2025Cited by 18
Impact of Proton Pump Inhibitor Use on Progression-Free and Overall Survival in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis of Recent StudiesGiuliana Ciappina, Massimiliano Berretta, Alessandro Ottaiano et al.|Cancers|2025Cited by 9
Multidisciplinary Integrative Medicine Approach for Cancer Patients: A Multicenter Retrospective StudyMassimiliano Berretta, Liliana Montella, Vincenzo Quagliariello et al.|Nutrients|2025Cited by 5
Fusobacteriumnucleatum: Pathophysiological and Clinical Involvement in Inflammatory Bowel Diseases, Colorectal Cancer and Cardiovascular DiseasesVincenzo Quagliariello, Massimiliano Berretta, Pietro Forte et al.|Cancers|2025Cited by 5
Investigating the Impact of Fusobacterium nucleatum on Oxidative Stress, Chemoresistance, and Inflammation in Inflammatory Bowel Disease and Colorectal Cancer: Rationale and Design of a Clinical TrialPierluigi Consolo, Massimiliano Berretta, Carlotta Giorgi et al.|International Journal of Molecular Sciences|2025Cited by 4